rTMS for Relieving Chronic OA Pain
WithdrawnNot applicableNCT05097729
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with pain due to knee osteoarthritis.
Study details
- Official title
- Transcranial Magnetic Stimulation to Enhance Cortical Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain
- Conditions
- Interventions
- Sponsor
- Northwestern University
- Start date
- 2021-11-15
- Primary completion
- 2022-12-01
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ≥ 6 months of knee pain on a daily basis; * male or female with no racial or ethnic restrictions; * 18 to 75 years old; * average knee pain intensity \> 4/10 at study entry; * must be able to read, understand, and sign consent form; * generally healthy. * able to use the PainApp Exclusion Criteria: * rheumatoid arthritis, ankylosing spondylitis, acute vertebral fractures, * Chronic neurologic conditions, e.g., Parkinson's * other severe medical diseases; * pregnancy; * positive urinary screen for any recreational drugs, * opioids use; * use of anticoagulants (low dose ASA allowed); * history of gastric ulcer; renal insufficiency or congestive heart failure, * contraindication to MRI, * contraindication to TMS; including history of seizure/epilepsy\* * Any medical condition that in the investigator's judgment may prevent the individual from completing the study or put the individual at undue risk; * In the judgment of the investigator, unable or unwilling to follow protocol and instructions. * Diagnosis of major depression.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05097729